Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JAN | JANUS LIVING INC | $8.13B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-11-02 | ||
| NKTX | NKARTA INC | $121.76M | $0.00 | -$105.57M | -$117.32M | -$1.57 | N/A | N/A | N/A | N/A | 2026-11-09 | ||
| ADTN | ADTRAN HOLDINGS INC | $560.59M | $1.14B | $97.52M | -$26.08M | -$0.28 | 15.75% | 16.34% | N/A | N/A | 2026-11-02 | ||
| MSGS | MADISON SQUARE GARDEN SPORTS CORP | $7.35B | $1.15B | $42.25M | $7.76M | $0.32 | 11.03% | 22.65% | N/A | N/A | 2026-10-30 | ||
| IPX | IPERIONX LTD | $492.11M | $0.00 | -$63.30M | -$66.77M | -$2.00 | N/A | N/A | N/A | N/A | |||
| PPLI | PEOPLE INC | $2.78B | $2.10B | $806.24M | $336.30M | $5.59 | -8.43% | -7.50% | N/A | -16.83% | 2026-11-02 | ||
| WHWK | WHITEHAWK THERAPEUTICS INC | $189.84M | $0.00 | -$79.82M | -$79.83M | -$1.15 | -100.00% | -100.00% | N/A | N/A | 2026-11-05 | ||
| NTHI | NEONC TECHNOLOGIES HOLDINGS INC | $77.81M | $0.00 | -$43.76M | -$47.20M | -$2.13 | -100.00% | N/A | N/A | N/A | 2026-11-13 | ||
| MMED | MINIMED GROUP INC | $5.33B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| PSQL | PASQAL HOLDING SA | $1.20B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| EVER | EVERQUOTE INC | $756.60M | $755.20M | $90.39M | $114.48M | $3.19 | 22.75% | 13.77% | 145.38% | N/A | 2026-11-02 | ||
| CEVA | CEVA INC | $883.19M | $115.73M | -$37.00k | -$10.98M | -$0.40 | 8.82% | 1.21% | N/A | N/A | 2026-11-09 | ||
| ELVN | ENLIVEN THERAPEUTICS INC | $3.20B | $0.00 | -$105.40M | -$105.93M | -$1.67 | N/A | N/A | N/A | N/A | 2026-11-11 | ||
| GHRS | GH RESEARCH PLC | $1.37B | $0.00 | -$61.63M | -$62.27M | -$1.00 | N/A | N/A | N/A | N/A | 2026-11-05 | ||
| VERU | VERU INC | $38.87M | $0.00 | -$13.50M | -$13.61M | -$0.58 | N/A | -100.00% | N/A | N/A | 2026-12-16 | ||
| ASML | ASML HOLDING NV | $626.59B | $44.20B | $19.13B | $15.09B | $39.23 | 19.06% | 16.71% | 40.40% | 20.57% | |||
| ACRS | ACLARIS THERAPEUTICS INC | $557.88M | $8.22M | -$75.32M | -$75.74M | -$0.58 | -51.05% | 4.39% | N/A | N/A | 2026-11-05 | ||
| QNT | QUANTINUUM INC | $10.59B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-11-05 | ||
| INFQ | INFLEQTION INC | $2.19B | $55.46M | -$83.09M | -$88.71M | -$1.16 | 30.76% | N/A | N/A | N/A | 2026-11-11 | ||
| FTW | PRESIDIO PRODUCTION CO | $319.21M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-11-10 | ||
| MBX | MBX BIOSCIENCES INC | $2.55B | $0.00 | -$103.82M | -$104.29M | -$2.36 | N/A | N/A | N/A | N/A | 2026-11-05 | ||
| AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | $1.39B | $95.69M | N/A | -$218.69M | -$2.35 | 73.48% | N/A | N/A | N/A | |||
| ARVN | ARVINAS INC | $487.13M | $316.70M | $14.90M | $9.30M | $0.27 | -15.05% | 66.28% | N/A | N/A | 2026-11-04 | ||
| ABTC | AMERICAN BITCOIN CORP | $564.35M | $271.67M | -$42.81M | -$194.92M | -$3.05 | 288.72% | 74.59% | N/A | N/A | 2026-11-04 | ||
| EDIT | EDITAS MEDICINE INC | $399.31M | $47.01M | -$73.54M | -$73.95M | -$0.69 | 20.83% | -10.34% | N/A | N/A | 2026-11-09 | ||
| TNGX | TANGO THERAPEUTICS INC | $3.86B | $53.81M | -$117.97M | -$123.72M | -$0.85 | 121.47% | 19.14% | N/A | N/A | 2026-11-03 | ||
| SRRK | SCHOLAR ROCK HOLDING CORP | $5.17B | $0.00 | -$390.64M | -$408.59M | -$3.32 | N/A | -100.00% | N/A | N/A | 2026-11-10 | ||
| SABS | SAB BIOTHERAPEUTICS INC | $279.33M | $0.00 | -$9.43M | -$12.78M | -$0.64 | -100.00% | -100.00% | N/A | N/A | 2026-11-13 | ||
| MANE | VERADERMICS INC | $5.88B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-11-10 | ||
| FDMT | 4D MOLECULAR THERAPEUTICS INC | $660.72M | $92.01M | -$171.05M | -$179.18M | -$2.63 | 278,712.12% | 31.93% | N/A | N/A | 2026-11-09 | ||
| REZI | RESIDEO TECHNOLOGIES INC | $2.78B | $7.65B | $866.00M | $363.00M | $2.42 | 3.42% | 5.85% | N/A | 5.75% | 2026-11-10 | ||
| RAPP | RAPPORT THERAPEUTICS INC | $1.32B | $20.00M | -$133.89M | -$137.16M | -$3.03 | N/A | N/A | N/A | N/A | 2026-11-05 | ||
| IMMX | IMMIX BIOPHARMA INC | $575.89M | $0.00 | -$39.40M | -$39.92M | -$0.88 | N/A | N/A | N/A | N/A | 2026-11-06 | ||
| SKHY | SK HYNIX INC | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| TLX | TELIX PHARMACEUTICALS LTD | $3.07B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| LONA | LEONABIO INC | $46.07M | $0.00 | -$140.22M | -$141.46M | -$23.11 | N/A | N/A | N/A | N/A | 2026-11-05 | ||
| KYMR | KYMERA THERAPEUTICS INC | $9.78B | $105.00M | -$291.04M | -$299.60M | -$3.25 | 134.84% | 10.22% | N/A | N/A | 2026-10-29 | ||
| SBET | SHARPLINK INC | $1.62B | $50.20M | -$1.71B | -$1.71B | -$11.80 | 1,496.87% | 94.41% | N/A | N/A | 2026-11-11 | ||
| CING | CINGULATE INC | $80.42M | $0.00 | -$28.21M | -$28.80M | N/A | N/A | N/A | N/A | N/A | 2026-11-12 | ||
| ASST | STRIVE INC | $2.32B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-11-09 | ||
| LTRX | LANTRONIX INC | $291.44M | $120.90M | -$872.00k | -$4.18M | -$0.10 | -1.65% | 11.08% | N/A | N/A | 2026-11-09 | ||
| STRO | SUTRO BIOPHARMA INC | $147.07M | $45.70M | -$169.19M | -$180.64M | -$17.36 | -56.25% | -7.86% | N/A | N/A | 2026-11-05 | ||
| DMRA | DAMORA THERAPEUTICS INC | $1.36B | $0.00 | -$262.39M | -$262.83M | $7.49 | N/A | N/A | N/A | -64.75% | 2026-11-05 | ||
| IAG | IAMGOLD CORP | $9.87B | $3.68B | $2.06B | $1.16B | $2.00 | 87.20% | 24.20% | 44.93% | 70.21% | 2026-11-05 | ||
| TTAN | SERVICETITAN INC | $7.87B | $1.06B | -$32.27M | -$129.00M | -$1.36 | 22.90% | N/A | N/A | N/A | 2026-12-03 | ||
| AGO | ASSURED GUARANTY LTD | $3.07B | $940.00M | $476.00M | $351.00M | $7.59 | -10.56% | -1.62% | -18.03% | 12.30% | 2026-11-05 | ||
| CADL | CANDEL THERAPEUTICS INC | $631.28M | $0.00 | -$82.78M | -$88.53M | -$1.42 | N/A | N/A | N/A | N/A | 2026-11-12 | ||
| WHK | WHITEHAWK MINERALS CORP | $738.49M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-11-12 | ||
| ACET | ADICET BIO INC | $35.67M | $0.00 | -$89.96M | -$98.97M | -$10.46 | N/A | -100.00% | N/A | N/A | 2026-11-04 | ||
| CLYM | CLIMB BIO INC | $549.66M | $0.00 | -$57.32M | -$57.62M | -$0.82 | N/A | N/A | N/A | N/A | 2026-11-05 | ||
| BEAM | BEAM THERAPEUTICS INC | $2.57B | $156.04M | -$63.18M | -$85.43M | -$0.68 | 158.88% | 478.90% | N/A | N/A | 2026-11-03 | ||
| STEP | STEPSTONE GROUP INC | $5.06B | $2.01B | -$718.66M | -$613.20M | -$7.68 | 48.46% | 11.65% | N/A | N/A | 2026-11-05 | ||
| TVRD | TVARDI THERAPEUTICS INC | $11.54M | $0.00 | -$25.89M | -$26.06M | -$2.85 | N/A | -100.00% | N/A | N/A | 2026-11-12 | ||
| BTGO | BITGO HOLDINGS INC | $664.13M | $20.07B | -$109.10M | -$95.75M | -$1.19 | 226.70% | N/A | N/A | N/A | 2026-11-11 | ||
| MNKD | MANNKIND CORP | $1.06B | $393.63M | $21.79M | -$43.61M | -$0.13 | 30.46% | 39.50% | N/A | N/A | 2026-11-04 | ||
| TDS | TELEPHONE & DATA SYSTEMS INC | $4.09B | $1.26B | $659.57M | $348.46M | $3.05 | 3.81% | -25.08% | N/A | 15.72% | 2026-11-06 | ||
| XNCR | XENCOR INC | $2.23B | $104.97M | -$123.60M | -$163.33M | -$2.17 | -28.56% | -10.09% | N/A | N/A | 2026-11-04 | ||
| ORIC | ORIC PHARMACEUTICALS INC | $932.87M | $0.00 | -$139.21M | -$140.35M | -$1.32 | N/A | N/A | N/A | N/A | 2026-11-12 | ||
| TRVI | TREVI THERAPEUTICS INC | $1.90B | $0.00 | -$51.04M | -$51.11M | -$0.34 | N/A | N/A | N/A | N/A | 2026-11-12 | ||
| XNDU | XANADU QUANTUM TECHNOLOGIES LTD | $894.42M | $7.21M | -$97.92M | -$105.98M | -$9.17 | 144.32% | N/A | N/A | N/A | 2026-11-04 | ||
| TRAX | FIRST TRACKS BIOTHERAPEUTICS INC | $1.62B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-11-11 | ||
| ABVX | ABIVAX SA | $6.93B | $5.77M | -$285.22M | -$460.11M | -$5.96 | -36.81% | N/A | N/A | N/A | 2026-12-21 | ||
| HIVE | HIVE DIGITAL TECHNOLOGIES LTD | $554.04M | $331.30M | -$112.88M | -$327.76M | -$1.32 | 157.52% | 27.05% | N/A | N/A | 2026-11-13 | ||
| BMA | MACRO BANK INC | $3.95B | $2.93B | $497.50M | $209.62M | $3.27 | -52.39% | -9.90% | -52.18% | -26.16% | 2026-11-25 | ||
| AKTS | AKTIS ONCOLOGY INC | $914.94M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-11-12 | ||
| PYXS | PYXIS ONCOLOGY INC | $153.47M | $11.04M | -$82.54M | -$88.73M | -$1.41 | 291.42% | N/A | N/A | N/A | 2026-11-02 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.